Russell Investments Group
LBRX

Russell Investments Group’s LB Pharmaceuticals LBRX Stock Holding History

Russell Investments Group’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Sell
34,074
-37,993
-53% -$1.12M ﹤0.01% 2411
2026
Q1 		$1.78M Buy
72,067
+70,542
+4,626% +$1.63M ﹤0.01% 1935
2025
Q4 		$33.9K Buy
+1,525
New +$26.6K ﹤0.01% 3440

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Russell Investments Group's LBRX Position: Q2 2026 in Review

Russell Investments Group reduced its LB Pharmaceuticals (LBRX) stake by 53% in Q2 2026, selling an estimated $1.12M and leaving 34,074 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Russell Investments Group first reported a position in LBRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.78M in Q1 2026. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Russell Investments Group held 34,074 shares of LB Pharmaceuticals worth $1.11M as of Q2 2026.
  • Russell Investments Group sold 37,993 LB Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • LB Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2411 holding.
  • Russell Investments Group first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Russell Investments Group's LB Pharmaceuticals position peaked at $1.78M in Q1 2026.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.